SCHEMBL3299381

SCHEMBL3299381

COc1cccc([SiH](O[SiH](c2ccccc2)c2cccc(OC)c2)c2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.48
ACHE P22303 1/20 0.45
MAOB P27338 1/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
LTA4H P09960 1/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2A6 P11509 1/20 0.41
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
ENPP2 Q13822 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3294227 0.94 ACHE (0.50) CA4ACHEALDH1A1CYP3A4CA1
SCHEMBL3296342 0.86 CA4 (0.44) CA4MAOBALDH1A1CYP3A4LTA4H
SCHEMBL3295781 0.82 CA4 (0.54) CA4ACHEALDH1A1CA1CA2
SCHEMBL3302339 0.80 ACHE (0.41) CA4ACHEALDH1A1CYP3A4LTA4H
SCHEMBL28088787 0.80 CA4 (0.52) CA4ACHEMAOBALDH1A1CYP3A4
SCHEMBL3299967 0.80 LTA4H (0.50) MAOBALDH1A1LTA4HSMN1; SMN2MEN1
SCHEMBL25008080 0.77 ACHE (0.54) CA4ACHEALDH1A1CYP3A4CA1
SCHEMBL3296208 0.77 CA12 (0.47) ALDH1A1CA1CA2CA7CA9
SCHEMBL3299926 0.76 ACHE (0.44) ACHEALDH1A1NPC1RAB9ALMNA
SCHEMBL308706 0.76 TSHR (0.35) CA4ACHEALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 CA4 1301/4885ACHE 3477/4885MAOB 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.